1,3-Dioxolane Test Results
|
||||||||||||||||||||||||||||||||||||||||
CAS No. 646-06-0
ITC Designation - Eleventh Report
47 FR 54626; December 3, 1982
Proposed Negotiated Testing Agreement (NTA)
48 FR 51839; November 14, 1983
Final Negotiated Testing Agreement (FAN)
49 FR 32113; August 10, 1984
Ferro Corporation and PPG Industries
Project Manager: L. Tuxen, R. Locke, R. Troast
Section Chief: R. Troast, R. Northrop
Status: Closed. All required tests have been completed. Test results
have been forwarded to the Risk Assessment Division for review and disposition.
An additional study of a type considered for future testing, a 90-day
inhalation subchronic study, was voluntarily submitted to EPA.
Announced Receipt of Test Data
Chromosomal aberration assay in CHO cells, in vitro cell transformation assay on Balb/C-3T3 cells, lymphoma forward mutagenicity assay (mouse) (50 FR31919; August 7, 1985).
On August 21, 1985, an independent laboratory audit was received of a 2-year drinking water chronic toxicity study of albino rats was received. The test was performed by Industrial Biotest Laboratory in 1975 (51 FR 6468; February 24, 1986).
![[logo] US EPA](http://www.epa.gov/epafiles/images/logo_epaseal.gif)